Neuvivo
Research - , ,
Neuvivo Employees
Neuvivo Senior Management
Neuvivo Details
Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We have developed a patented macrophage-targeted technology, NP001, that addresses chronic inflammation, a key factor in the progressive loss of motor function in ALS.NP001 has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are working to move this compound toward approval and delivering an effective and safe new treatment for ALS.
Website:
http://www.neuvivo.com
Employees:
7
HQ:
Location:
, ,
Revenue:
Neuvivo Technologies
Email Providers
Gmail
Customer Relationship Management
Salesforce
CMS
WordPress.org
Other
Mobile Friendly
CSS and JavaScript Libraries
Bootstrap Framework